Laurus Labs Limited
LAURUSLABS
Hisse Senetlerindeki Sıralama
#1737
Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited,... Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited, along with its subsidiaries, operates as a diversified global pharmaceutical company. It focuses on the research, manufacturing, and international distribution of a broad spectrum of medicines and active pharmaceutical ingredients (APIs). The company's API and advanced intermediate offerings cover key therapeutic domains such as anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C. Additionally, Laurus Labs develops and produces oral solid dosage forms targeting ARV, antidiabetic, cardiovascular, PPI, and central nervous system (CNS) conditions. Beyond its proprietary products, the firm extends its expertise through contract development and manufacturing services for other pharmaceutical enterprises. It also supplies specialized ingredients vital for nutraceutical, dietary supplement, and cosmeceutical applications. Furthermore, Laurus Labs is at the forefront of innovation, engineering novel enzymatic solutions for industrial biotechnology, and providing animal-origin-free recombinant proteins and enzymes for biopharmaceutical use, alongside offering a range of business support services within the pharmaceutical industry.
Hisse Fiyatı
$22.83
Son senkronizasyon: 2026-10-19
Piyasa Değeri
$12.34B
Değişim (1 gün)
0.51%
Değişim (1 yıl)
117.95%
Ülke
IN
Ticaret Laurus Labs Limited (LAURUSLABS)
Kategori
Healthcare
Laurus Labs Limited (LAURUSLABS) için tedavüldeki hisse sayısı
June 2026 itibarıyla tedavüldeki hisse sayısı: 539.79M
Laurus Labs Limited şirketinin son finansal raporlarına ve hisse fiyatına göre, mevcut tedavüldeki hisse sayısı 539.79M'dir. March 2024 sonunda şirketin 540.57M tedavüldeki hissesi vardı. Tedavüldeki hisse sayısı genellikle hisse bölünmeleri ve hisse geri alımları ile etkilenir.
Laurus Labs Limited (LAURUSLABS) için 2013 - 2026 tarihleri arasındaki hisse geçmişi
Her yıl sonunda tedavüldeki hisse sayısı
| Yıl | Tedavüldeki Hisse Sayısı | Değiştir |
|---|---|---|
| 2026 (TTM) | 539.79M | 0.03% |
| 2025 | 539.64M | -0.17% |
| 2024 | 540.57M | 0.16% |
| 2023 | 539.69M | 0.11% |
| 2022 | 539.10M | 0.19% |
| 2021 | 538.06M | 0.87% |
| 2020 | 533.42M | 0.13% |
| 2019 | 532.75M | 0.19% |
| 2018 | 531.76M | 16.15% |
| 2017 | 457.83M | -6.95% |
| 2016 | 492.04M | 10.95% |
| 2015 | 443.48M | 0.00% |
| 2014 | 443.48M | 9.11% |
| 2013 | 406.44M | 0.00% |
Benzer şirketler veya rakipler için tedavüldeki hisse sayısı
| Şirket | Tedavüldeki Hisse Sayısı | Fark | Ülke |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 344.49% |
IN
|
